As part of the University of Virginia's Foundations of Biomedical Data Science seminar series, this pre-recorded lecture explores how coded data in electronic medical records (EMR) provides vast amounts of valuable patient data. However, effectively applying data science tools to this data requires understanding dataset limitations and avoiding common false assumptions.
Preliminary results from the NIH-funded ACTIV-1 immune modulators clinical trial show that treating adults hospitalized with COVID-19 with infliximab or abatacept — drugs widely used to treat certain autoimmune diseases — substantially improves clinical status and reduces deaths. The CTSA Program and Trial Innovation Network played a key role in enrolling participants in the U.S. More than half of the CTSA Program hubs also contributed their infrastructure and expertise to help advance the clinical trial.
Bringing together all the latest news in recruitment and retention, conference proceedings, papers, and training events, this online bulletin is a quick and easily accessible summary of what is happening in the world of clinical trial recruitment.
Needing to “train” their computer using deidentified EHR data from people who had reported a COVID-19 infection, researchers found just what they needed in the National COVID Cohort Collaborative (N3C), a national, publicly available data resource sponsored by NCATS.
If you have a story, opportunity, project or event that you'd like included in the News Roundup, please contact CLIC Communications: email@example.com or visit the CLIC Library to learn how to post content to the CLIC website
The University of Rochester Center for Leading Innovation and Collaboration (CLIC) is the coordinating center for the Clinical and Translational Science Awards (CTSA) Program, funded by the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH), Grant U24TR002260.